Women's Health & Gynecology Clinical Trials Update: Week 32, 2026
Published August 7, 2026 — 5 trials covered
By Victor Lafforgue, Founder of TrialsAlert. Blog posts are AI-drafted from ClinicalTrials.gov source data and reviewed by the editorial team. See our editorial policy for details.
Bupropion for the Prevention of Postpartum Smoking Relapse
A Phase 4 trial led by the University of Minnesota tested whether the medication bupropion can help new mothers avoid starting smoking again after childbirth. This study involved 161 women in the United States who took the medication daily for 12 weeks beginning shortly after delivery. If bupropion proves effective, it could provide a valuable tool to support mothers in staying smoke-free, which benefits both their health and the health of their babies.
Comparison of the Efficacy of Misoprostol and Tranexamic Acid for Postpartum Hemorrhage Prophylaxis in Cesarean Delivery
This trial conducted at Ankara Etlik City Hospital in Turkey compared two drugs, misoprostol and tranexamic acid, to prevent heavy bleeding after cesarean delivery. Heavy bleeding after childbirth can lead to serious complications, so finding the best prevention method is important for safer recoveries. The study enrolled 192 women, and results are awaited to understand which medication might better protect mothers during cesarean births.
Closed-loop Double-vasopressor Automated System to Treat Hypotension During Spinal Anaesthesia for Caesarean Section
A Phase 2 study at KK Women’s and Children’s Hospital tested a new automated system designed to manage low blood pressure during spinal anesthesia for cesarean sections. Low blood pressure during surgery can affect both mother and baby, so this technology aims to improve safety by automatically adjusting treatment. The study involved 216 women, and the results will show whether this system can better support mothers during cesarean deliveries.
Influencing Next-Generation Oncologic Outcomes Through Rapid Integration of Functional Precision Medicine (NOORI): A Feasibility Study of SmartMatch in Rare Gynecologic Cancers
This ongoing study by Fred Hutchinson Cancer Center is exploring a personalized approach called SmartMatch for women with advanced or metastatic gynecologic cancers. By analyzing tissue samples, the study seeks to identify tailored treatment options beyond standard therapies. The trial is currently recruiting patients in the United States and represents hope for more individualized cancer care in difficult-to-treat cases.
SOPHIE Trial: Surgery in Ovarian Cancer With PreHabilitation In ERAS
Researchers in Spain conducted a study testing a special prehabilitation program before surgery for women with advanced ovarian cancer. The program aims to improve recovery and reduce complications after surgery, potentially helping patients start chemotherapy sooner. With 158 participants, the trial’s results will help determine if this approach can support better outcomes for women facing ovarian cancer surgery.
TrialsAlert subscribers received the full impact-classified briefing and doctor-ready report this week. Get weekly briefings at trialsalert.com.